Search research articles
Contact Us
Filters
Showing results (151-160 of 159) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 159 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 21, 2024
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial
Devin Schellenberg, Zsolt Gabos, Adele Duimering, et al.
Nature Communications
|
February 28, 2014
Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue
Jianxin Shi, Crystal N Marconett, Jubao Duan, et al.
BMC Cancer
|
February 3, 2024
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET
Robert Olson, Hadassah Abraham, Curtis Leclerc, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2025
Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial
David A Palma, Eitan Prisman, Eric Berthelet, et al.
JAMA Oncology
|
April 28, 2022
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial
David A Palma, Eitan Prisman, Eric Berthelet, et al.
BMC Cancer
|
February 16, 2020
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial
Anthony C Nichols, Pencilla Lang, Eitan Prisman, et al.
Cell Reports. Medicine
|
June 19, 2024
Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities
Parth Desai, Nobuyuki Takahashi, Rajesh Kumar, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 159) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 159 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 21, 2024
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial
Devin Schellenberg, Zsolt Gabos, Adele Duimering, et al.
Nature Communications
|
February 28, 2014
Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue
Jianxin Shi, Crystal N Marconett, Jubao Duan, et al.
BMC Cancer
|
February 3, 2024
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET
Robert Olson, Hadassah Abraham, Curtis Leclerc, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2025
Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial
David A Palma, Eitan Prisman, Eric Berthelet, et al.
JAMA Oncology
|
April 28, 2022
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial
David A Palma, Eitan Prisman, Eric Berthelet, et al.
BMC Cancer
|
February 16, 2020
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial
Anthony C Nichols, Pencilla Lang, Eitan Prisman, et al.
Cell Reports. Medicine
|
June 19, 2024
Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities
Parth Desai, Nobuyuki Takahashi, Rajesh Kumar, et al.
Page
of 16